Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tecartus
Tecartus
Gilead's Tecartus gets revised safety demand amid FDA's push for CAR-T boxed warnings
Fierce Pharma
Wed, 01/24/24 - 10:46 am
Gilead Sciences
Tecartus
CAR-T
FDA
Kite gets US FDA approval for Tecartus to treat acute lymphoblastic leukemia
Pharmaceutical Business Review
Mon, 10/4/21 - 10:39 am
Kite Pharma
Gilead Sciences
Tecartus
FDA
ALL
acute lymphoblastic leukemia
ASCO21: Gilead sets up first FDA okay for adult ALL with Tecartus data
Pharmaforum
Mon, 06/7/21 - 11:07 am
ASCO 2021
Gilead Sciences
Tecartus
ALL
#ASCO21: A week after nabbing priority review, Kite unveils the pivotal data it hopes will lead to a new CAR-T approval
Endpoints
Sat, 06/5/21 - 02:25 pm
ASCO 2021
Kite Pharma
Gilead Sciences
CAR-T
Tecartus
OptumRx's 3 recently approved drugs to watch
Beckers Hospital Review
Tue, 09/22/20 - 10:15 pm
FDA
Kite Pharma
Tecartus
Novartis
Kesimpta
MorphoSys
Monjuvi
OptumRx
Gilead’s Kite Pharma gets FDA nod for second CAR-T cell therapy
MedCity News
Sat, 07/25/20 - 02:29 pm
Gilead Sciences
CAR-T
KTE-X19
Tecartus
FDA
Kite Pharma